ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

37
Analysis
Health CareIndia
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
Refresh
bearishLaurus Labs
07 Dec 2016 15:09

Laurus Labs IPO - Fluctuating Margins and Inconsistent Growth Muddle past Record

Laurus labs aims to raise up to US$200m through a mix of primary and secondary issuance of shares.Our fellow insight provider Kemp Dolliver, CFA...

Logo
215 Views
Share
bearishLaurus Labs
05 Dec 2016 03:49

Laurus Labs: Final Thoughts

The company has announced a price range of Rs 426 - 428 per share for its listing with bidding set to open on 6 December and closing on 8 December...

Share
bullishLaurus Labs
25 Nov 2016 04:24

Laurus Labs IPO Overview

India-based Laurus Labs has filed for a listing on the BSE and NSE, and reportedly plans to raise up to Rs300 crore for debt repayment and general...

Share
22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
4.8k Views
Share
01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective:  2014 Actual...

Share
x